10% CONVERTIBLE PROMISSORY NOTE DUE FEBRUARY 27, 2017Premier Biomedical Inc • June 3rd, 2016 • Biological products, (no disgnostic substances) • New York
THIS 10% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10% Convertible Promissory Notes of Premier Biomedical Inc. (the "Company"), having its principal place of business at P.O. Box 31374, El Paso, TX 79930, designated as its 10% Convertible Notes due February 27, 2017 (this Note, the "Note" and, collectively with the other Notes of such series, the "Notes").
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 3rd, 2016 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this "Agreement") is made and entered into as of May 27, 2016, between Premier Biomedical, Inc., a Nevada corporation (the "Company"), and Redwood Management, LLC a Florida limited liability company (together with its permitted assigns, (the "Buyer"). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 3rd, 2016 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • New York
This Stock Purchase Agreement (this "Agreement") is dated as of May 27, 2016, by and between Premier Biomedical, Inc., a Nevada corporation (the "Company"), and Redwood Management, LLC, a Florida limited liability company (the "Investor").
